These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8386902)

  • 1. Are leukotrienes or PAF involved in hyperbaric oxygen toxicity?
    Lin Y; Jamieson D
    Agents Actions; 1993 Jan; 38(1-2):66-75. PubMed ID: 8386902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
    de Lima WT; Sirois P; Jancar S
    Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.
    Vaananen PM; Keenan CM; Grisham MB; Wallace JL
    Inflammation; 1992 Jun; 16(3):227-40. PubMed ID: 1323529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway responsiveness in transgenic mice overexpressing platelet-activating factor receptor. Roles of thromboxanes and leukotrienes.
    Nagase T; Ishii S; Katayama H; Fukuchi Y; Ouchi Y; Shimizu T
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1621-7. PubMed ID: 9372685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAF-induced conjunctivitis in the rabbit is mediated by peptido-leukotrienes.
    Muller A; Meynier F; Bonne C
    J Ocul Pharmacol; 1990; 6(3):227-32. PubMed ID: 1963192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits.
    Herd CM; Donigi-Gale D; Shoupe TS; Page CP
    Br J Pharmacol; 1992 Dec; 107(4):1108-15. PubMed ID: 1467833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
    Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal damage induced by platelet-activating factor: role of leukotrienes.
    Wallace JL; MacNaughton WK
    Eur J Pharmacol; 1988 Jun; 151(1):43-50. PubMed ID: 2843390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperoxic lung damage in mice: appearance and bioconversion of peptide leukotrienes.
    Smith LJ; Shamsuddin M; Anderson J; Hsueh W
    J Appl Physiol (1985); 1988 Mar; 64(3):944-51. PubMed ID: 2835352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-lipoxygenase inhibitor, FR110302, suppresses airway hyperresponsiveness and lung eosinophilia induced by Sephadex particles in rats.
    Asano M; Inamura N; Nakahara K; Nagayoshi A; Isono T; Hamada K; Oku T; Notsu Y; Kohsaka M; Ono T
    Agents Actions; 1992 Jul; 36(3-4):215-21. PubMed ID: 1382375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the coronary vascular effects of platelet-activating factor in the rat perfused heart.
    Hu W; Kinnaird AA; Man RY
    Br J Pharmacol; 1991 May; 103(1):1097-102. PubMed ID: 1652337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung.
    Davidson D; Drafta D
    J Appl Physiol (1985); 1992 Sep; 73(3):955-61. PubMed ID: 1400062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G; Fennessy M
    Br J Pharmacol; 1988 Aug; 94(4):1115-22. PubMed ID: 3145088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation.
    Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich PP; Darlington JV; Stock NS; Zunic J; King CD; Lee C; Baccei CS; Stearns B; Roppe J; Hutchinson JH; Prasit P; Evans JF
    Eur J Pharmacol; 2010 Aug; 640(1-3):211-8. PubMed ID: 20519143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of leukotrienes and platelet activating factor in acute gastric mucosal lesions in rats.
    Konturek SJ; Brzozowski T; Drozdowicz D; Garlicki J; Beck G
    Eur J Pharmacol; 1989 May; 164(2):285-92. PubMed ID: 2759176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by lipid mediators of immune complex-induced lung inflammation in mice.
    Steil AA; Tavares de Lima W; Jancar S
    Eur J Pharmacol; 1998 Nov; 361(1):93-9. PubMed ID: 9851546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paf-induced release of spasmogens from guinea-pig lungs.
    Jancar S; Thériault P; Lauzière M; Braquet P; Sirois P
    Br J Pharmacol; 1989 Jan; 96(1):153-62. PubMed ID: 2538179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG; Nossi DF; Sirois P; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
    Ford-Hutchinson AW
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.